ストックスクリーナーアプリを入手
4.40
0.00%
0.00
アフターアワーズ：
4.50
0.10
+2.27%
前日終値:
$4.40
開ける：
$4.45
24時間の取引高:
4,065
Relative Volume:
0.48
時価総額：
$40.84M
収益：
$70,100
当期純損益:
$-9.67M
株価収益率:
-3.8224
EPS:
-1.1511
ネットキャッシュフロー:
$-7.09M
1週間 パフォーマンス:
-14.23%
1か月 パフォーマンス:
-47.74%
6か月 パフォーマンス:
-56.82%
1年 パフォーマンス:
-56.52%
1日の値動き範囲:
$4.35
$4.89
1週間の範囲:
$4.35
$5.335
52週間の値動き範囲:
$4.35
$18.40
Exozymes Inc Stock (EXOZ) Company Profile
Compare EXOZ vs VRTX, REGN, ARGX, RVMD, ALNY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
4.40 | 42.23M | 70,100 | -9.67M | -7.09M | -1.1511 |
VRTX
Vertex Pharmaceuticals Inc
|
483.33 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
695.42 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
882.56 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
180.92 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.62 | 37.17B | 4.29B | 577.22M | 641.34M | 4.2086 |
Exozymes Inc (EXOZ) 最新ニュース
eXoZymes Inc (EXOZ) Income Statement - TradingKey
eXoZymes Inc (EXOZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
eXoZymes Inc (EXOZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
eXoZymes Inc (EXOZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
eXoZymes Inc (EXOZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
eXoZymes Inc (EXOZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
EXOZ|eXoZymes Inc|Price:4.500|Chg%:-0.210 - TradingKey
eXoZymes Inc. Revenue Breakdown – NASDAQ:EXOZ - TradingView
eXoZymes Inc (EXOZ) Cash Flow - TradingKey
eXoZymes Inc (EXOZ) Balance Sheet - TradingKey
eXoZymes Inc (EXOZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
eXoZymes Inc (EXOZ) Institutional Confidence - TradingKey
eXoZymes Inc. (EXOZ) Slides Amid Biotech Volatility: Key Levels to WatchDay Trade Opportunities - dars.gov.et
eXoZymes, Inc. (EXOZ) Stock Price, News, Quote & History - Yahoo! Finance Canada
exoZymes selected for DOE Genesis Mission AI project By Investing.com - Investing.com Nigeria
exoZymes selected for DOE Genesis Mission AI project - Investing.com
EXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing - marketscreener.com
eXoZymes and Berkeley Lab Develop AI-Powered Digital Twins - Stock Titan
eXoZymes Inc. (EXOZ) Holds Steady Near Support as Trading Volume Remains NormalADD Alert - dars.gov.et
eXoZymes (EXOZ) Stock Gains 3.76% as Buyers Hold Above Key SupportGrowth Stock Picks - dars.gov.et
If You Invested $1,000 in Invizyne Technologies Inc (IZTC) - Stock Titan
Enterprise value to EBITDA forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
Price to sales forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
Enterprise value to EBIT forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
eXoZymes Inc. (EXOZ) Slips 2.96% – Testing Key Support Near $7.17Smart Beta Flow - dars.gov.et
Enterprise value to revenue forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
Price to earnings forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
eXoZymes Completes New Securities Offering to Fund Pipeline - TipRanks
eXoZymes Raises $0.64 Million Via Unit Offering; Adds MDB Placement Pact and Warrant Coverage - TradingView
eXoZymes (NASDAQ: EXOZ) raises $639K in unit sale with resettable warrants - Stock Titan
Form 424B5 eXoZymes Inc For: 30 June - Investing.com UK
Form 424B5 eXoZymes Inc For: 30 June By Investing.com - Investing.com India
eXoZymes (EXOZ) raises net $565K; warrants exercisable 6/5/2027–2031 - Stock Titan
eXoZymes Secures $2M NIH Grant to Advance AI-Engineered Cannabinoid Analogs for Drug Discovery - Minichart
eXoZymes Secures NIH Grant to Advance Cannabinoid Pipeline - TipRanks
eXoZymes awarded $2.03M NIH SBIR grant to develop cannabinoid analogs - TradingView
eXoZymes (NASDAQ: EXOZ) lands $2,028,518 NIH grant for cannabinoid analog R&D - Stock Titan
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - The National Law Review
exoZymes receives $2M NIH grant for cannabinoid research - Investing.com
EXoZymes receives $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - marketscreener.com
eXoZymes stock rises on $2M NIH grant for cannabinoid work - Investing.com South Africa
eXoZymes stock rises on $2M NIH grant for cannabinoid work By Investing.com - Investing.com Australia
exoZymes receives $2M NIH grant for cannabinoid research By Investing.com - Investing.com UK
NIH backs eXoZymes' cannabinoid drug discovery work with $2M grant - Stock Titan
eXoZymes Inc (EXOZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
eXoZymes Inc (EXOZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
eXoZymes closes $5.95M public offering of stock and warrants By Investing.com - Investing.com Australia
eXoZymes Completes Nasdaq Equity Offering to Fund Pipeline - TipRanks
Exozymes Raises $5.95 Million in Underwritten Equity Offering Led by MDB Capital - TradingView
eXoZymes (NASDAQ: EXOZ) closes $5.95M stock and warrant unit offering - Stock Titan
Exozymes Inc (EXOZ) 財務データ
収益
当期純利益
現金流量
EPS
Exozymes Inc (EXOZ) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Korman Tyler Paz | Chief Scientific Officer |
Apr 08 '26 |
Sale |
10.04 |
750 |
7,530 |
729,873 |
0.54%
2.87%
大文字化:
|
ボリューム (24 時間):